Cited by 331Cholesterol and Lipid MetabolismLipoproteins and Cardiovascular HealthParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

The metabolism and anti-atherogenic properties of HDL

Open access

Rye, Kerry-Anne, Bursill, Christina A., Lambert, Gilles, Tabet, Fatiha, Barter, Philip J.·2009·Journal of Lipid Research

DOI 10.1194/jlr.r800034-jlr200PMC PMC2674714

Open this paper in CoChat — free account

Abstract

Population studies have shown that plasma HDL levels correlate inversely with cardiovascular disease risk. In recent years there has been intense interest in developing strategies for exploiting these cardioprotective properties by increasing HDL levels. While this approach has considerable merit, it is important to recognize that HDL are structurally and functionally diverse and consist of numerous, highly dynamic subpopulations of particles that do not all inhibit atherosclerosis to the same extent. For this reason it is essential to assess HDL subpopulation distribution and functionality when considering therapeutic interventions that raise HDL levels. This review documents what is known about the relationship between the metabolism and function of HDL subpopulations and how this affects their cardioprotective properties.

Integrity signals

Registry

Crossref · 10.1194/jlr.r800034-jlr200

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Self-citation
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events
Barter, P., Gotto, A. M., LaRosa, J. C., Maroni, J., Szarek, M., Grundy, S. M., Kastelein, J. J. P., Bittner, V., & Fruchart, J.-C. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064278 · Cited by 1,610
Self-citation
New Insights Into the Regulation of HDL Metabolism and Reverse Cholesterol Transport
Lewis, G. F., & Rader, D. J. (2005) · Circulation Research · doi:10.1161/01.res.0000170946.56981.5c · Cited by 1,104
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Rużyłło, W., Bachinsky, W., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 968
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules
COCKERILL, G. W., Rye, K., Gamble, J. R., Vadas, M. A., & Barter, P. J. (1995) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.15.11.1987 · Cited by 788
Self-citation
Effects of an Inhibitor of Cholesteryl Ester Transfer Protein on HDL Cholesterol
Brousseau, M. E., Schaefer, E. J., Wolfe, M. L., Bloedon, L. T., Digenio, A. G., Clark, R. W., Mancuso, J. P., & Rader, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031766 · Cited by 774
Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.
Badimón, J. J., Badimón, L., & Fuster, V. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114558 · Cited by 764
Endothelial and Antithrombotic Actions of HDL
Mineo, C., Deguchi, H., Griffin, J. H., & Shaul, P. W. (2006) · Circulation Research · doi:10.1161/01.res.0000225982.01988.93 · Cited by 663

Show all 51 references

Sorted by citations

Items 201–300 of 331

Slim Body Weight Is Highly Associated With Enhanced Lipoprotein Functionality, Higher HDL-C, and Large HDL Particle Size in Young Women
Park, K.-H., Yadav, D., Kim, S., Kim, J., & Cho, K. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00406 · Cited by 9
The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism
Moradi, M., Mahmoudi, M., Saedisomeolia, A., Zahirihashemi, R., & Koohdani, F. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0255-4 · Cited by 8
Apolipoprotein A-I anti-tumor activity targets cancer cell metabolism
Zamanian-Daryoush, M., Lindner, D. J., Buffa, J. A., Gopalan, B., Na, J., Hazen, S. L., & DiDonato, J. A. (2020) · Oncotarget · doi:10.18632/oncotarget.27590 · Cited by 8
Association between Lipoprotein Subfractions, Hemostatic Potentials, and Coronary Atherosclerosis
Flerin, T. P., Mijovski, M. B., & Jug, B. (2022) · Disease Markers · doi:10.1155/2022/2993309 · Cited by 9
Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk
Pikó, P., Jenei, T., Kósa, Z., Sándor, J., Kovács, N., Seres, I., Paragh, G., & Ádány, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210281 · Cited by 8
Pressure perturbation calorimetry of apolipoproteins in solution and in model lipoproteins
Benjwal, S., & Gursky, O. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22637 · Cited by 8
Validation of a novel homogeneous assay for of HDL3-C measurement
Ashmaig, M., Gupta, S., McConnell, J. P., & Warnick, G. R. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.07.007 · Cited by 8
Atorvastatin and Fenofibrate Increase the Content of Unsaturated Acyl Chains in HDL and Modify In Vivo Kinetics of HDL-Cholesteryl Esters in New Zealand White Rabbits
Flores‐Castillo, C., Luna‐Luna, M., Carreón‐Torres, E., López‐Olmos, V., Frı́as, S., Juárez-Oropeza, M. A., Franco, M., Fragoso, J. M., Vargas‐Alarcón, G., & Pérez-Méndez, O. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102521 · Cited by 8
Multiple facets of HDLs as modifiable risk factors in stroke—the good, the bad, and the ugly
Krishnamoorthy, S., Manjunatha, S., Damayanthi, D., Sylaja, P. N., & Gopala, S. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100879 · Cited by 8
Cardiometabolic risk factors are affected by interaction between FADS1 rs174556 variant and dietary vegetable oils in patients with diabetes: a randomized controlled trial
Fallah, Z., Vasmehjani, A. A., Aghaei, S., Amiri, M., Raeisi‐Dehkordi, H., Moghtaderi, F., Zimorovat, A., Yazd, E. F., Madadizadeh, F., Khayyatzadeh, S. S., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-78294-6 · Cited by 7
Association of Novel Hematological Indices with Severity of Coronary Artery Disease using SYNTAX Score in Patients with Acute Coronary Syndrome
Mohanty, V., Sharma, S. K., Goswami, S., Kaushik, A., Choudhary, R., Yadav, D., Deora, S., & Singh, K. (2023) · Cardiovascular & Haematological Disorders - Drug Targets · doi:10.2174/011871529x269740231102045028 · Cited by 7
Abnormal glucose and lipid control in non-ischemic left ventricular dysfunction
Neglia, D., Sampietro, T., Vecoli, C., Liga, R., Rossi, G., Filidei, E., Bigazzi, F., Iozzo, P., Giannessi, D., L’Abbate, A., et al. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9609-7 · Cited by 7
Advanced diagnostic support in lipidology project: role for phenotypic and functional evaluation of lipoproteins in dyslipidemias
Ardigò, D., Bernini, F., Borghi, C., Calandra, S., Cicero, A. F. G., Favari, E., Fellin, R., Franzini, L., Vigna, G. B., Zimetti, F., et al. (2010) · Clinical Lipidology · doi:10.2217/clp.10.20 · Cited by 7
Protein changes in non-LDL-lipoproteins in familial hypercholesterolemia: implications in cardiovascular disease manifestation and outcome
Badimón, L., Padró, T., & Cubedo, J. (2017) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000441 · Cited by 7
High‐efficient bacterial production of human ApoA‐I amyloidogenic variants
Giudice, R. D., & Lagerstedt, J. O. (2018) · Protein Science · doi:10.1002/pro.3522 · Cited by 7
Is Anacetrapib Better Than Its CETP Inhibitor Counterparts?
Grabie, M., Tai, C.-H., & Frishman, W. H. (2018) · Cardiology in Review · doi:10.1097/crd.0000000000000245 · Cited by 6
Desmodium gyrans dc modulates lipid trafficking in cultured macrophages and improves functional high-density lipoprotein in male wistar rats
Raghavamenon, A. C., Indu, M. S., Narayanankutty, A., Ramavarma, S. K., Manalil, J. J., & Padikkala, J. (2021) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_136_17 · Cited by 6
Activity of serum paraoxonase 1, lipid profile and atherogenic indexes in diabetic induced rats treated with alpha lipoic acid
Jamor, P., Ahmadvand, H., Birjandi, M., & Sharafabad, B. E. (2018) · Journal of Nephropathology · doi:10.15171/jnp.2018.49 · Cited by 6
Evaluation of Serum Paraoxonase, Myeloperoxidase, and HDL-Cholesterol Levels in Acute Myeloid Leukemia
Sincan, S., Sincan, G., Aşkın, S., & Kızıltunç, A. (2023) · Inflammation · doi:10.1007/s10753-023-01924-0 · Cited by 5
Interaction between APOE, APOA1, and LPL Gene Polymorphisms and Variability in Changes in Lipid and Blood Pressure following Orange Juice Intake: A Pilot Study
Fraga, L. N., Milenković, D., Coutinho, C. P., Rozenbaum, A. C., Lajolo, F. M., & Hassimotto, N. M. A. (2023) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202200847 · Cited by 5
Vitamin D levels and lipid profile in children and adolescents: a tight correlation
Ceruti, D., Colombo, C., Loiodice, M., Leo, S. D., Calcaterra, V., & Fabiano, V. (2024) · Minerva Pediatrics · doi:10.23736/s2724-5276.23.07352-4 · Cited by 6
Atherogenic Indices and HDL Particle Size as Laboratory Parameters to Evaluate Cardiovascular Risk in the Presence of Dyslipidemia
dos Santos, A. P. C., Vieira, M. S., Deus, D. F., de Oliveira, R. J. B., Morikawa, A. T., Aras, R., Atta, A. M., Couto, F. D., Maranhão, R. C., & Couto, R. D. (2014) · Journal of Biophysical Chemistry · doi:10.4236/jbpc.2014.52004 · Cited by 5
Neo High-Density Lipoprotein Produced by the Streptococcal Serum Opacity Factor Activity against Human High-Density Lipoproteins Is Hepatically Removed via Dual Mechanisms
Rodriguez, P. J., Gillard, B. K., Barosh, R., Gotto, A. M., Rosales, C., & Pownall, H. J. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00946 · Cited by 5
Optimization of PCR Condition: The First Study of High Resolution Melting Technique for Screening of APOA1 Variance.
Wahyuningsih, H., Cayami, F. K., Bahrudin, U., Sobirin, M. A., Mundhofir, F. E., Faradz, S. M., & Hisatome, I. (2017) · PubMed Central · Cited by 5
Lipoprotein Metabolism and Cholesterol Balance
Acuña, M., & Cohen, D. E. (2020) · Wiley eBooks · doi:10.1002/9781119436812.ch22 · Cited by 5
ABCA1-Mediated Structural Diversity of HDL Subspecies and Their Proposed Roles in Cardioprotection
Heinecke, J. W., Segrest, J. P., Phillips, M. C., & Davidson, W. S. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.318266 · Cited by 4
Efecto del ejercicio en subpoblaciones de lipoproteínas de alta densidad y en la presión arterial
Nieto, O., García, D. M., Jiménez, J., & Landázuri, P. (2013) · Revista de Salud Pública · Cited by 4
Atherosclerosis
Libby, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2930-6.00008-2 · Cited by 4
Evaluating the Impact of Defeasible Argumentation as a Modelling Technique for Reasoning under Uncertainty
Rizzo, L. (2020) · Arrow - TU Dublin (Technological University Dublin) · doi:10.21427/g02a-wg20 · Cited by 4
Apolipoprotein B/Apolipoprotein A1 ratio is an independent prognostic factor in pancreatic cancer
Li, C., Yang, X., Zhong, Y., Wang, W., Jin, X., Bian, L., & Wang, X. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102208 · Cited by 3
Anacetrapib
Robinson, L. B., & Frishman, W. H. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000023 · Cited by 3
High prevalence of low high‐density lipoprotein cholesterol and insulin resistance among children and adolescents living with HIV in Uganda: harbinger for metabolic syndrome?
Kisitu, G. P., Shabanova, V., Naiga, F., Nakagwa, M., Kekitiinwa, A., Elyanu, P., & Paintsil, E. (2023) · HIV Medicine · doi:10.1111/hiv.13570 · Cited by 3
Derivation of a new formula for the estimation of low-density lipoprotein cholesterol
Gowda, S. H., Huchegowda, R., Kumawat, R., Goswami, B., & Lali, P. (2019) · Indian Journal of Health Sciences and Biomedical Research (KLEU) · doi:10.4103/kleuhsj.kleuhsj_86_19 · Cited by 3
Protein tyrosine phosphatase inhibition down-regulates ligand-induced ABCA1 expression
Luu, W., Sharpe, L. J., & Brown, A. J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.016 · Cited by 3
Data-driven analysis of the relationship between the HbA1c/HDL-C ratio and coronary artery calcification: a cross-sectional study
Chen, C., Li, M., Yan, G., Zhang, W., & Tang, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-07469-6 · Cited by 2
A Fluorescence-Based In Vitro Method to Assess Cholesterol Efflux
Fernández‐Castillejo, S., Pedret, A., Catalán, Ú., & Solà, R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1924-7_15 · Cited by 2
Developing and Validating a New Model to Predict the Risk of Poor Neurological Status of Acute Ischemic Stroke After Intravenous Thrombolysis
Liu, L., & Wang, W. (2023) · The Neurologist · doi:10.1097/nrl.0000000000000506 · Cited by 2
Hypolipidemic Activity of Aqueous Extract of Turnip (Brassica rapa) Root in Hyperlipidemic Rats
nejad, S. V., Serki, E., Fard, M. H., & Hosseini, M. (2015) · Quarterly of Horizon of Medical Sciences · doi:10.18869/acadpub.hms.21.1.45 · Cited by 2
HYPOGLYCEMIC EFFECT OF LUPIN ALKALOIDS AND/OR ROSIGLITAZONE IN PREGNANT DIABETIC RATS IN RELATION TO ATHEROGENIC INDEX
Mosaad, M. N., Awaad, M. H., El-hodairy, F. E.-H., El-Zayat, S. R., Ibrahim, S., Salama, S. F., & El-Azma, M. H. (2014) · International Journal of Pharmacy and Pharmaceutical Sciences · Cited by 2
High-Density Lipoprotein: Is the Good Cholesterol Turning Bad?
Inankur, A., Nicholls, S. J., & Jahangiri, A. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0143-3 · Cited by 2
CETP inhibition in perspective
Stock, J. K. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.10.008 · Cited by 2
Lipoprotein in cholesterol transport: Highlights and recent insights into its structural basis and functional mechanism
Chen, S.-Y., Li, N., Jin, T.-L., Gou, L., Hao, D., Tian, Z., Zhang, S., & Zhang, L. (2018) · Chinese Physics B · doi:10.1088/1674-1056/27/2/028702 · Cited by 2
Serum Paraoxonase-1 Activity in Rheumatoid Arthritis Patients as a Risk Factor for Cardiovascular Comorbidity
Elshabacy, F. A., El-Rahman, S. K. A., El-Maghraby, A., Aissa, E., & Amer, E. (2015) · Egyptian Journal of Rheumatology & Clinical Immunology · doi:10.21608/ejrci.2015.9303 · Cited by 2
Plant‐Derived Manufacturing of Apolipoprotein AI Milano : Purification and Functional Characterization
Nykiforuk, C. L., Shen, Y., Murray, E. L., Boothe, J. G., & Moloney, M. M. (2012) · doi:10.1002/9781118356807.ch20 · Cited by 2
Efeito em hamsters da suplementação dietética com gorduras ricas em ácidos graxos saturados, monoinsaturados ou poliinsaturados sobre a transferência de lípides para a lipoproteína de alta densidade (HDL)
Maniero, F. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-28092009-141657 · Cited by 2
Aging and Cholesterol Metabolism
Auley, M. T. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-22009-9_122 · Cited by 2
Novel insights into the causal effects of triglycerides to high density lipoprotein cholesterol ratio on blood pressure
Wan, A.-H., Han, Y., Wu, L., Wei, Y., Xiang, X., Chen, Y., Chen, J., Song, A., & Zhao, K. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104474 · Cited by 2
Associations between lipid-derived indices and cardiovascular–kidney–metabolic syndrome progression among Chinese middle-aged and elderly adults: a longitudinal study
Tang, Y. R., Xu, W., Jiang, Y., Liu, C., Zhu, W., Liu, D., Fu, X., & Wu, Q. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1742974 · Cited by 2
Biologics for cardiovascular diseases: from bench to bedside
Sun, X., Wang, X., Jia, R., Tang, J., Zeng, X. Y., Zhao, F., Zeng, F., Huang, N., Li, J., & Cui, K. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02673-w · Cited by 2
Association of non-conventional lipid-inflammatory parameters with incident hypertension risk: a prospective cohort study
Zhao, M., Wang, M., Li, Z., Wu, Y., Lu, F., & Li, Q. (2026) · Journal of Global Health · doi:10.7189/jogh.16.04237 · Cited by 1
Hypertriglyceridemia in an outpatient department – Significance as an atherosclerotic risk factor
Scholz, M., Tselmin, S., Fischer, S., & Julius, U. (2015) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2015.02.011 · Cited by 2
CARDIOVASCULAR DISEASE RISK FACTOR ESTIMATION IN GUJARATI ASIAN INDIAN POPULATION USING FRAMINGHAM RISK EQUATION
Sahoo, S., Shah, K. H., Shukla, A., Prajapati, J., & Shah, P. (2014) · National Journal of Medical Research · Cited by 1
Uticaj prisustva metabolickog sindroma na nalaz testa fizickim opterecenjem
Crncevic, N. (2016) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1663027c · Cited by 1
Enhancement of HDL by Policosanol
Cho, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-7383-1_3 · Cited by 1
Change of HDL by Life Style
Cho, K. (2019) · Springer eBooks · doi:10.1007/978-981-13-7387-9_2 · Cited by 1
Ersonified diagnostic and correction dyslipidemia approach by profiling of apolipoproteins
Kachkovsky, M. A., Vvedenskaya, I. P., Vvedensky, V. Y., Supilnikov, A. A., Ponomareva, J. V., & Milyakova, M. N. (2020) · Bulletin of the Medical Institute REAVIZ (REHABILITATION DOCTOR AND HEALTH) · doi:10.20340/vmi-rvz.2020.4.11 · Cited by 1
A Closer Look at Cardioprotective Function of HDL: Revise the HDL – Cholesterol Hypothesis?
Meiliana, A., & Wijaya, A. (2014) · The Indonesian Biomedical Journal · doi:10.18585/inabj.v6i1.40 · Cited by 1
Fish and Fish Oil and Lipoprotein Particle Number and Size
Erkkilä, A. T., & Lankinen, M. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802844-5.00022-1 · Cited by 1
Agent-based modeling predicts HDL-independent pathway of removal of excess surface lipids from very low density lipoprotein
Paalvast, Y., Kuivenhoven, J. A., Bakker, B. M., & Groen, A. K. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.06.052 · Cited by 2
Three two-site apoA-I immunoassays using phage expressed detector antibodies – Preliminary clinical evaluation with cardiac patients
Negi, P., Heikkilä, T., Tallgrén, T., Malmi, P., Lund, J., Sinisalo, J. P., Metso, J., Jauhiainen, M., Pettersson, K. S. I., Lamminmäki, U., et al. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113772 · Cited by 1
Lipid Transport
Meisenberg, G., & Simmons, W. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07155-0.00025-3 · Cited by 1
THE RELATIONSHIP OF MORNING SURGE in BLOOD PRESSURE and ATHEROGENIC INDEX
Kılıç, O. (2023) · Eskisehir Medical Journal Eskisehir City Hospital · doi:10.48176/esmj.2023.139 · Cited by 1
Atherosclerosis II : HDL Elevation
Ali, A., Hunt, J. A., & Sinclair, P. J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc193 · Cited by 1
Déficit familial de la LCAT au Québec : description d’une première mutation et contribution du génotype de l’APO E sur le phénotype lipoprotéique
Baass, A. W. (2009) · doi:10.71781/26883 · Cited by 1
Cinética plasmática da lipoproteína de baixa densidade e avaliação dos aspectos qualitativos da lipoproteína de alta densidade em indivíduos com artrite reumatóide
Pozzi, F. S. (2012) · doi:10.11606/t.5.2012.tde-25042012-113656 · Cited by 1
Oxidized LDL and physical fitness in healthy young men: associations with body composition, smoking, metabolic syndrome and androgen status
Kosola, J. A. (2013) · UTUPub (University of Turku) · Cited by 1
Aging and Cholesterol Metabolism
Auley, M. T. M. (2019) · Springer eBooks · doi:10.1007/978-3-319-69892-2_122-1 · Cited by 1
Exploration of precision coregulator TR-FRET identifies diverse signatures for LXR ligands relevant to discovery of nonlipogenic ABCA1 inducers
Laham, M. S., Ackerman-Berrier, M. S., Alam, F., Turner, S., Velma, G. R., Penton, C., Musku, S. R., Rana, M., Thulasingam, S., Anandhan, A., et al. (2025) · eLife · doi:10.1101/2025.09.12.675753 · Cited by 1
In search of nonlipogenic ABCA1 inducers (NLAI): precision coregulator TR-FRET identifies diverse signatures for LXR ligandsPreprint
Laham, M. S., Ackerman-Berrier, M. S., Alam, F., Turner, S., Velma, G. R., Penton, C., Musku, S. R., Rana, M., Kumar, S., Anandhan, A., et al. (2025) · eLife · doi:10.7554/elife.109146.1 · Cited by 1
NÍVEIS SÉRICOS DE VITAMINA D ASSOCIADOS COM INDICADORES DA SÍNDROME METABÓLICA NA POPULAÇÃO BRASILEIRA.
Pesarini, J. R. (2013) · Americanae (AECID Library) · Cited by 1
Effect of non-esterified fatty acids on insulin resistance and cardiovascular risk in polycystic ovary syndrome
Aye, M. M. (2013) · Repository@Hull (Worktribe) (University of Hull) · Cited by 1
Modulation of vascular inflammation: cell type specific effects by ADAMs and HDL
van der Vorst, E. P. C. (2015) · doi:10.26481/dis.20150521ev
Effects of tocotrienol rich fractions on lipid profiles in hemodialysis patients
Hanna, R. (2013) · Human Biology
Lipoproteína de alta densidade (HDL) isolada de portadores de diabete melito tipo 2 com controle glicêmico inadequado favorece o acúmulo de colesterol em macrófagos
Pereira, P. H. G. R. (2009) · doi:10.11606/d.5.2009.tde-08032010-102308
Efeitos da suplementação de manteiga e margarinas no metabolismo lipídico e inflamação de portadores de síndrome metabólica que mantiveram seus hábitos usuais de vida
Miguel, A. C. M. G. (2010) · doi:10.11606/t.5.2010.tde-19032010-112343
Movilización intracelular de colesterol mediada por apoA-I y dHDL: dominios proteicos involucrados
Cabaleiro, L. V. (2013) · doi:10.35537/10915/28974
Effects of corticosteroid treatment on high-density lipoprotein distribution and function
Cakan, Y. (2014) · The Sydney eScholarship Repository (The University of Sydney)
Emerging Lipoprotein-Related Therapeutics for Patients with Diabetes
Little, P. J., Chait, A., Januszewski, A. S., Bobik, A., O'Neal, D. N., & Jenkins, A. J. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_23
Thematic Review Series: New Lipid and Lipoprotein Targets for the Treatment of Cardiometabolic Diseases Cholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk
Barter, P. J., & Rye, K. (2012)
Self-citation
Paraoxonase: The boon against oxidative stress and lipid peroxidation
Kumar, A. (2013) · Journal of Biomedical Science
Cholesterol HDL — przyjaciel czy wróg? Cholesterol HDL — friend or foe?*
Banach, J., & Bydgoszcz (2013)
Functional activities of HDL particles in acute myocardial infarction : dissection of the roles of proteome vs. lipidome components
Rached, F. H. (2013)
Ucestalost metabolickog sindroma kod gojaznih ucesnika programa Cigota
Crncevic, N. (2016) · Medicinski glasnik Specijalna bolnica za bolesti stitaste zlezde i bolesti metabolizma Zlatibor · doi:10.5937/medgla1661036c
HDL-kolesteroløkning : Vil farmakoterapi føre til bedret prognose?
Aalen, J. M. (2010) · NORA - Norwegian Open Research Archives
HDL zawierające apolipoproteinę E a rozwój miażdżycy* ApoE-containing HDL and the development of atherosclerosis
Strzelecki, A., Kortas‐Stempak, B., & Zdrojewski, Z. (2015)
Prevention of Murine Atherosclerosis with Bempedoic Acid
Samsoondar, J. P. (2016) · Scholarship@Western (Western University)
Validation Of A Novel Hypothesis Of Generating Foam Cells By Its Use To Study Reverse Cholesterol Transport
Sengupta, B. (2014) · Journal of International Crisis and Risk Communication Research
Atheroinflammatory Properties of LDL and HDL Particles Modified by Human Mast Cell Neutral Proteases
Maaninka, K. (2018) · Työväentutkimus Vuosikirja
Cholesterol efflux as a measure of HDL functionality in humans
Talbot (2018) · doi:10.26481/dis.20180419ct
Nutritional Factors Impacting Intestinal Lipid Metabolism Using a Model of Low Birth Weight Swine
Fontaine, M. A. (2018) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3dr2pq51
Atherosclerosis in Rheumatology: Old and New Insights
Oreská, S., & Tomčík, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.88605
Evaluation of type-2 diabetes mellitus patients for dyslipidemia in a tertiary care centre
Chokshi, J. G., Gandhi, A. P., Parmar, I. M., & Damor, D. R. (2020) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20201078
Bone Mineral Density and Lipid Metabolism After Alendronate and Strontium Ranelate Treatment
Özay, Ö. E., Özay, A. C., & Acar, B. (2020) · Cyprus Journal of Medical Sciences · doi:10.5152/cjms.2020.1923
Aktueller Stellenwert der HDL-Cholesterin-Bestimmung für die kardiovaskuläre Risikoabschätzung
Annema, W. (2021) · Praxis · doi:10.1024/1661-8157/a003677
Intestinal Microbiota and Bacterial Translocation: Impact of Diet, Obesity and Insulin Resistance
Singh, V. P. (2019) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3-gba2-gr59
The impact of different sources of fatty acids on the fetal programming of atherosclerosis
Gates, L. J. (2021) · Nottingham ePrints (University of Nottingham)
Current World Literature
(2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e3283382286
Biologic Activities
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch7
Metabolism
Kontush, A., & Chapman, M. J. (2011) · Wiley eBooks · doi:10.1002/9781118158678.ch4
Lipid Fractions and Severity of Coronary Artery Lesions in Acute Myocardial Infarction: A Retrospective Single-Center Study
Rexhepi, A., Asani, V., & Ibrahimi, V. (2022) · Journal of Medical and Health Studies · doi:10.32996/jmhs.2022.3.3.3

Authors: Rye, K.-A., Bursill, C. A., Lambert, G., Tabet, F., & Barter, P. J.
Affiliations: The University of Sydney (AU)
The Heart Research Institute (AU)
Corresponding author: Rye, Kerry-Anne
ORCID: Bursill, Christina A.
Lambert, Gilles
Venue: Journal of Lipid Research
Publisher: Elsevier BV
Published: 2009-04
Volume: 50
Pages: S195-S200
ISSN: 0022-2275 (ISSN-L)
DOI: 10.1194/jlr.r800034-jlr200
PMC: PMC2674714
OpenAlex: W1967702791
Cited by: 331
References: 51
Citations by year: 2026: 13 · 2025: 14 · 2024: 12 · 2023: 17 · 2022: 15 · 2021: 16 · 2020: 16 · 2019: 17 · 2018: 21 · 2017: 13 · 2016: 9 · 2015: 27 · 2014: 21 · 2013: 48 · 2012: 20
FWCI: 2.90
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 4185 d)
Locations: Journal of Lipid Research (publishedVersion, cc-by)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: HDL metabolism, HDL subpopulations, atherosclerosis, cardioprotection, cardiovascular risk, HDL function, HDL-targeted therapy
MeSH terms: Animals, Antioxidants, Humans, Inflammation, Cholesterol, HDL, Genetic Heterogeneity, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The metabolism and anti-atherogenic properties of HDL

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks